Home/NanoMosaic/Dr. Qimin Quan

DQ

Dr. Qimin Quan

Co-Founder & Chief Scientific Officer

Therapeutic Areas

Neurology Gene Therapy

NanoMosaic Pipeline

Drug	Indication	Phase
AAV Gene Therapy QC	AAV capsid and transgene characterization	Commercial (RUO)
Blood pTau Detection	Alzheimer's Disease and Related Dementias	Development

Leadership Team at NanoMosaic

Philippe Mourere

Chief Executive Officer & VP of Software Development

Co-Founder (Managing Director, TigerGene Ventures)

View full NanoMosaic profile